INS 13th World Congress Pre-Conference:
Innovations in Neuromodulation - May 28, 2017

The International Neuromodulation Society is pleased to announce "Innovations in Neuromodulation. The Challenge of Reimbursement: Can we do this smarter?" -- its fourth educational event for the neuromodulation innovation and investment community, which will take place on Sunday, 28 May 2017, in Edinburgh, Scotland, as part of the official pre-conference of the INS 13th World Congress. (Note: The date has changed from the 27th of May to the 28th.) This unique event will bring together over 200 leaders in the global neuromodulation and investment communities to share the wealth of their experiences, and their visions for the future of this exciting and rapidly evolving field.  

In this Innovations Day, INS is presenting an opportunity for innovators to share their company stories with venture capitalists, clinicians, engineers and other Industry members. 

Invited speakers will include representatives from National Institute of Health Research, NICE, and BSI group (a notified body). Year on year this has become very popular and demonstrates the complex interactions and roles that inventors, investors, researchers, clinicians, regulators have in developing safe and effective devices to benefit both patients and the health care system.


We have developed the program with an aim of achieving several objectives:

  • Identify and discuss the data that needs to be collected by commercialising companies to ensure it has utility for future reimbursement applications.

  • Learn about the process by which innovations occur, become funded, receive reimbursement and reach the marketplace.

  • Describe the process of establishing and protecting intellectual property.

  • Define the regulatory process by which the CE Mark and FDA approval are obtained in Europe and in the U.S., respectively, and ultimately earn full reimbursement.

  • Learn about what public scientific initiatives are available with which to partner.

  • Find out about current and future investment strategies and challenges in the device market --both in Europe and in the U.S.

  • Discover emerging companies and the science behind their innovative therapies.

  • Network with the leaders in innovation, investment, basic science and clinical practice in the neuromodulation space.

Click here to register to attend the pre-conference sessions and main INS Congress.

Please feel free to contact the INS Executive Office with any questions about the pre-conference or main congress.

We hope to see you in Edinburgh!


Dr. Simon Thomson,
INS Immediate Past-President
Co-Chair, INS Scientific Committee and Innovations in Neuromodulation

Dr. Marc Russo
INS Secretary
Co-Chair, Innovations in Neuromodulation

Dr. Jeffrey Arle
Dr. Philippe Rigoard
Dr. Konstantin Slavin

Previous Participating Companies

12th World Congress in Montreal - 2015
Axonics Modulation Technologies
BlueWind Medical
CorTec
FemPulse LLC
Lungpacer Medical Inc.
Medtronic Eindhoven Design Center, formerly Sapiens Steering Brain Stimulation
MicroTransponder
Neuronano AB
Neuros Medical
SPR Therapeutics
WISE Srl

11th World Congress in Berlin - 2013
Aleva Neurotherapeutics
Algostim
Biotectix
Endostim
Functional Neuromodulation
Mainstay Medical
NeuroNexus
Neuros Medical
NeuroSigma
Neurotargeting
Nexstim Oy
Sapiens Steering Brain Stimulation
Stimwave Technologies
WISE Srl

10th World Congress in London - 2011
Autonomic Technologies
Cerebral Rx
Functional Neuromodulation
ImThera Medical
NDI Medical
Neuros Medical
Nevro Corp.
QiG Group / Algostim
Spinal Modulation


 Apply Now to Participate on the Emerging Company Panels


Return to the Congress Home Page

 
Last Updated on Saturday, May 06, 2017 11:55 AM